Lighthouse Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,171
Closed -$568K 78
2025
Q4
$568K Sell
11,171
-650
-5% -$33.2K 0.37% 36
2025
Q3
$656K Sell
11,821
-4,680
-28% -$274K 0.43% 37
2025
Q2
$1.14M Sell
16,501
-3,400
-17% -$231K 0.87% 24
2025
Q1
$1.38M Sell
19,901
-1,150
-5% -$95K 1.19% 20
2024
Q4
$1.81M Buy
+21,051
New +$2.28M 1.47% 19

Other funds holding NVO

Lighthouse Financial's NVO Position: Q1 2026 in Review

Lighthouse Financial sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 11,171 shares — an estimated $568K sold.

Lighthouse Financial first reported a position in NVO in Q4 2024 and held it in 5 quarters. The position peaked at $1.81M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Lighthouse Financial reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Financial sold 11,171 Novo Nordisk shares in Q1 2026, an estimated $568K.
  • Lighthouse Financial first reported a position in Novo Nordisk in Q4 2024 and held it in 5 quarters.
  • Lighthouse Financial's Novo Nordisk position peaked at $1.81M in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Lighthouse Financial's 13F filing for Q1 2026, filed 14 May 2026.